Table 3.
Incidence of AEFIs according to the used vaccine during the active reporting survey.
| National pharmacovigilance survey | |||
|---|---|---|---|
| No. of immunized subjects (N = 1000) | No. of subjects reporting AEFIs (N = 771) | Incidence (%) | |
| Adjuvanted vaccine | |||
| Arepanrix | 549 | 451 | 82.1 |
| Pandemrix | 359 | 281 | 78.3 |
| Non-adjuvanted vaccine | |||
| Panenza | 92 | 39 | 42.4 |